Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers’

So Yun Lim; Jineui Kim; Ji-Soo Kwon; Sung-Woon Kang; Seung-Beom Kim; Woori Kim; Ju Yeon Son; Choi Young Jang; Heedo Park; Jeonghun Kim; Sohyun Lee; Kyung Taek Kim; Jaeuk Choi; Ji Yeun Kim; Joon Seo Lim; Euijin Chang; Seongman Bae; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Man-Seong Park; Sung-Han Kim

doi:10.1002/ctm2.1551

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1551 DOI: 10.1002/ctm2.1551

LETTER TO THE JOURNAL

Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers’

Author information +

History +

PDF

Cite this article

Download citation ▾

So Yun Lim, Jineui Kim, Ji-Soo Kwon, Sung-Woon Kang, Seung-Beom Kim, Woori Kim, Ju Yeon Son, Choi Young Jang, Heedo Park, Jeonghun Kim, Sohyun Lee, Kyung Taek Kim, Jaeuk Choi, Ji Yeun Kim, Joon Seo Lim, Euijin Chang, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Man-Seong Park, Sung-Han Kim. Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers’. Clinical and Translational Medicine, 2024, 14(1): e1551 DOI:10.1002/ctm2.1551

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Corbett KS, Nason MC, Flach B, et al. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science. 2021;373(6561):eabj0299.

[2]	Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205-1211.

[3]	Feng S, Phillips DJ, White T, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032-2040.

[4]	Hall V, Foulkes S, Insalata F, et al. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N Engl J Med. 2022;386(13):1207-1220.

[5]	Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the Omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23(5):556-567.

[6]	Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Protective effect of previous SARS-CoV-2 infection against Omicron BA.4 and BA.5 subvariants. N Engl J Med. 2022;387(17):1620-1622.

[7]	Malato J, Ribeiro RM, Leite PP, et al. Risk of BA.5 infection among persons exposed to previous SARS-CoV-2 variants. N Engl J Med. 2022;387(10):953-954.

[8]	Barda N, Canetti M, Gilboa M, et al. The association between prebooster vaccination antibody levels and the risk of severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2023;76(7):1315-1317.

[9]	Lim JME, Tan AT, Le Bert N, Hang SK, Low JGH, Bertoletti A. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8⁺ and CD4⁺ T cells of broad specificity. J Exp Med. 2022;219(10):e20220780.

[10]	Havervall S, Marking U, Svensson J, et al. Anti-spike mucosal IgA protection against SARS-CoV-2 Omicron infection. N Engl J Med. 2022;387(14):1333-1336.

[11]	Williamson S, Munro C, Pickler R, Grap MJ. Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract. 2012;2012:246178.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.